surgery

Surgery in melanoma

Surgery is a central melanoma treatment category, especially when melanoma is localized or removable. The exact plan depends on stage, location, pathology, and whether lymph node evaluation is needed.

Plain-English summary

Surgery conversations often focus on what is being removed, margins, sentinel lymph node biopsy, and what the final pathology might change.

What the sources say

• NCI PDQ describes surgery as a core treatment category for localized melanoma and selected recurrent/metastatic situations.
• Surgical decisions depend on stage, site, pathology details, and whether lymph-node assessment is part of the plan.
• MatchMedi frames surgery as a question pathway because pathology after surgery can change the medical-oncology conversation.

When this commonly comes up

• A biopsy-proven melanoma needs local removal.
• The team is deciding whether lymph node evaluation is needed.
• A recurrent or metastatic spot needs tissue confirmation or symptom-focused local control.

What this does not mean

• Surgery alone does not always answer whether systemic therapy or surveillance is needed.
• A clear margin does not replace a staging conversation.

Important cautions

• Final pathology can change the plan.
• Ask who coordinates the handoff from surgery to medical oncology if risk is higher than expected.

Questions to ask

• What margin is planned and why?
• Is sentinel lymph node biopsy being considered?
• What pathology result would change the next step?
• Should medical oncology be involved before or after surgery?